Tawara et al., demonstrated that WT-1 specific TCR-T cells manipulated ex vivo survived in vivo and induced immune responses in WT-1-positive HLA-A*24:02 positive AML and MDS patients. The gene discussed is WT1; the disease is myelodysplastic syndrome.